Lifting the smokescreen Britton J., Godfrey F. Eur Respir J 2006; 27: 871-873 |   |
COPD, asthma and C-reactive protein Anderson G. P. Eur Respir J 2006; 27: 874-876 |   |
The systemic face of airway diseases: the role of C-reactive protein Wouters E. F. M. Eur Respir J 2006; 27: 877-879 |   |
Sniff nasal inspiratory pressure: simple or too simple? Vogelmeier C., Costabel U., Fitting J-W. Eur Respir J 2006; 27: 881-883 |   |
Multiple inflammatory hits and the pathogenesis of severe airway disease Pavord I. D., Birring S. S., Berry M., Green R. H., Brightling C. E., Wardlaw A. J. Eur Respir J 2006; 27: 884-888 |    |
Combined transbronchial needle aspiration and positron emission tomography for mediastinal staging of NSCLC Bernasconi M., Chhajed P. N., Gambazzi F., Bubendorf L., Rasch H., Kneifel S., Tamm M. Eur Respir J 2006; 27: 889-894 |    |
Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer Dooms C. A., Lievens Y. N., Vansteenkiste J. F. Eur Respir J 2006; 27: 895-901 |    |
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients de Torres J. P., Cordoba-Lanus E., Lopez-Aguilar C., Muros de Fuentes M., Montejo de Garcin... A., Aguirre-Jaime A., Celli B. R., Casanova C. Eur Respir J 2006; 27: 902-907 |    |
High sensitivity C-reactive protein in asthma Takemura M., Matsumoto H., Niimi A., Ueda T., Matsuoka H., Yamaguchi M., Jinnai M., Muro S., Hirai T., Ito Y., Nakamura T., Mio T., Chin K., Mishima M. Eur Respir J 2006; 27: 908-912 |    |
New aspects of airway mechanics in pre-term infants Henschen M., Stocks J., Brookes I., Frey U. Eur Respir J 2006; 27: 913-920 |    |
A controlled trial of a school-based intervention to improve asthma management McCann D. C., McWhirter J., Coleman H., Calvert M., Warner J. O. Eur Respir J 2006; 27: 921-928 |    |
Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis Barker M., Hengst M., Schmid J., Buers H-J., Mittermaier B., Klemp D., Koppmann R. Eur Respir J 2006; 27: 929-936 |    |
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Proesmans M., Balinska-Miskiewi... W., Dupont L., Bossuyt X., Verhaegen J., Hoiby N., de Boeck K. Eur Respir J 2006; 27: 937-943 |    |
Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Brannan J. D., Gulliksson M., Anderson S. D., Chew N., Seale J. P., Kumlin M. Eur Respir J 2006; 27: 944-950 |    |
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma van Veen I. H., Sterk P. J., Schot R., Gauw S. A., Rabe K. F., Bel E. H. Eur Respir J 2006; 27: 951-956 |    |
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Guddo F., Vignola A. M., Saetta M., Baraldo S., Siena L., Balestro E., Zuin R., Papi A., Maestrelli P., Fabbri L. M., Bonsignore G., Turato G. Eur Respir J 2006; 27: 957-963 |    |
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Leigh R., Pizzichini M. M. M., Morris M. M., Maltais F., Hargreave F. E., Pizzichini E. Eur Respir J 2006; 27: 964-971 |    |
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial Andreas S., Herrmann-Lingen C., Raupach T., Luthje L., Fabricius J. A., Hruska N., Korber W., Buchner B., Criee C-P., Hasenfuss G., Calverley P. Eur Respir J 2006; 27: 972-979 |    |
Sniff nasal inspiratory pressure: what is the optimal number of sniffs? Lofaso F., Nicot F., Lejaille M., Falaize L., Louis A., Clement A., Raphael J-C., Orlikowski D., Fauroux B. Eur Respir J 2006; 27: 980-982 |    |
Noninvasive detection of expiratory flow limitation in COPD patients during nasal CPAP Dellaca R. L., Rotger M., Aliverti A., Navajas D., Pedotti A., Farre R. Eur Respir J 2006; 27: 983-991 |    |
Characteristics of tracheostomy phonation valves Prigent H., Orlikowski D., Blumen M. B., Leroux K., Legrand L., Lejaille M., Falaize L., Ruquet M., Raphael J-C., Lofaso F. Eur Respir J 2006; 27: 992-996 |    |
Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study El Solh A. A., Saliba R., Bosinski T., Grant B. J. B., Berbary E., Miller N. Eur Respir J 2006; 27: 997-1002 |    |
Mandibular advancement and obstructive sleep apnoea: a method for determining effective mandibular protrusion Dort L. C., Hadjuk E., Remmers J. E. Eur Respir J 2006; 27: 1003-1009 |    |
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia Aspa J., Rajas O., Rodriguez de Cast... F., Huertas M. C., Borderias L., Cabello F. J., Tabara J., Hernandez-Flix S., Martinez-Sanchis A., Torres A. Eur Respir J 2006; 27: 1010-1019 |    |
Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Fukuda Y., Yanagihara K., Higashiyama Y., Miyazaki Y., Hirakata Y., Mukae H., Tomono K., Mizuta Y., Tsukamoto K., Kohno S. Eur Respir J 2006; 27: 1020-1025 |    |
Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery van de Visse E. P., van der Heijden M., Verheij J., van Nieuw Amerong... G. P., van Hinsbergh V. W. M., Girbes A. R. J., Groeneveld A. B. J. Eur Respir J 2006; 27: 1026-1032 |    |
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy Wewel A. R., Crusius J. A. M., Gatzemeier U., Heckmayr M., Becher G., Magnussen H., Jorres R. A., Holz O. Eur Respir J 2006; 27: 1033-1039 |    |
Quantifying physical activity in daily life with questionnaires and motion sensors in COPD Pitta F., Troosters T., Probst V. S., Spruit M. A., Decramer M., Gosselink R. Eur Respir J 2006; 27: 1040-1055 |    |
Lymphangioleiomyomatosis Johnson S. R. Eur Respir J 2006; 27: 1056-1065 |    |
Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient Shah S., Budev M., Blazey H., Fairbanks K., Mehta A. Eur Respir J 2006; 27: 1066-1068 |    |
Obstructive ventilatory defect with normal forced expiratory volume in one second/vital capacity ratio Stanescu D. Eur Respir J 2006; 27: 1069-1070 |   |
From the authors Pellegrino R., Brusasco V., Crapo R. O., Viegi G. Eur Respir J 2006; 27: 1070 |   |
Inhaler technique blind spot Crompton G. K. Eur Respir J 2006; 27: 1070-1071 |   |
From the authors Van Ganse E., Laforest L. Eur Respir J 2006; 27: 1071 |   |
External validity of randomised controlled trials in idiopathic pulmonary fibrosis Thomeer M. Eur Respir J 2006; 27: 1072 |   |
From the authors Raghu G., Johnson W. C. Eur Respir J 2006; 27: 1072-1073 |   |
Training and ventilatory assistance in chronic obstructive pulmonary disease Bianchi L. Eur Respir J 2006; 27: 1074 |   |
From the authors van 't Hul A., Gosselink R. Eur Respir J 2006; 27: 1074-1075 |   |
Making sense of the chest x-ray: a hands on guide Verschakelen J. Eur Respir J 2006; 27: 1071 |   |
THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD. D. DUSSER, M-L. BRAVO AND P. IACONO, ON BEHALF OF THE MISTRAL STUDY GROUP. EUR RESPIR J 2006; 27: 547-555. Eur Respir J 2006; 27: 1076 |   |
THE POTENTIAL IMPACT OF ANAEMIA OF CHRONIC DISEASE IN COPD. T. SIMILOWSKI, A. AGUSTI, W. MACNEE AND B. SCHONHOFER. EUR RESPIR J 2006; 27: 390-396. Eur Respir J 2006; 27: 1076 |   |